Indivior's Stock Soars 90% Since April on Optimism for Sublocade

Indivior (INDV) is a specialty pharmaceutical company with a market value of $3.03 billion. Its stock has risen 90% since April, driven by optimism for Sublocade, an extended-release injection for opioid use disorder. Technical indicators are overwhelmingly bullish, with a 100% "Buy" rating from Barchart. However, the stock is volatile and speculative, requiring strict risk management and stop-loss strategies.

Indivior PLC (LON:INDV), a specialty pharmaceutical company, has seen its stock rise significantly, driven by optimism surrounding its Sublocade product, an extended-release injection for opioid use disorder. The stock has increased by approximately 90% since April, with technical indicators overwhelmingly bullish, as indicated by a 100% "Buy" rating from Barchart [1].

Recent Performance:
On July 1, 2025, Indivior PLC's stock crossed above its 50-day moving average, reaching a high of GBX 1,264 ($16.78) before closing at GBX 1,238 ($16.44) [1]. This move is significant as it suggests a potential trend reversal, with the stock trading above its 50-day moving average for the first time in recent history.

Financial Highlights:
Indivior PLC reported a net income of $18 million in the second quarter of 2025, up from a $97 million net loss in the same period last year [2]. Net revenues inched up by 1% to $302 million, primarily driven by the strong performance of its Sublocade drug. The company also raised its full-year 2025 net revenue guidance to a range of $1.03 billion to $1.08 billion [2].

Technical Indicators:
Barchart's technical indicators are overwhelmingly bullish, with a 100% "Buy" rating. This indicates a strong consensus among analysts and traders that the stock is poised for further gains [1].

Volatility and Risk Management:
Despite the positive outlook, the stock remains volatile and speculative. Investors should exercise strict risk management strategies, including the use of stop-loss orders to mitigate potential losses.

Conclusion:
Indivior PLC's stock performance has been driven by strong earnings reports and optimism surrounding its Sublocade product. With technical indicators overwhelmingly bullish and the stock trading above its 50-day moving average, investors may find Indivior an attractive opportunity. However, the volatility of the stock necessitates cautious investing and a well-defined risk management strategy.

References:
[1] https://www.marketbeat.com/instant-alerts/indivior-lonindv-stock-passes-above-fifty-day-moving-average-time-to-sell-2025-07-31/
[2] https://finance.yahoo.com/news/indivior-plc-indv-jumps-22-163204788.html